<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067508</url>
  </required_header>
  <id_info>
    <org_study_id>06-12-097-03</org_study_id>
    <nct_id>NCT01067508</nct_id>
  </id_info>
  <brief_title>Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women</brief_title>
  <official_title>Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this research study is to determine by laboratory analyses the effects of drinking
      silicon-rich water on bone health. This will be determined from blood and urine samples from
      subjects who will be asked to drink 1 liter per day of either silicon-rich water or water
      without silicon for 12 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Naturally occurring silicon as aqueous silicic acids at a level of 85 mg/liter which is well
      within safe intake limits occurs in water obtained from artesian wells in Fiji (Fiji Water,
      Inc.). Other drinking waters (e.g. Aquafina, Crystal Geyser, etc.) have all trace minerals
      including silicon removed by reverse osmosis. Silicon may be a necessary mineral for bone
      health. Therefore, this study aims to demonstrate the potential beneficial effects of
      short-term intake of silicon-rich water (85 mg/day of silicon in the diet from 1 liter of
      Fiji Water) compared to deionized water (with no silicon) over 12 weeks in normal
      postmenopausal women. The women to be studied will be stratified by bone density (based on T
      score by DEXA) and have analyses of biomarkers of bone metabolism to achieve the following
      specific aims:

        1. To conduct a prospective randomized controlled trial in two mixed groups of 15 normal
           postmenopausal women and osteopenic pre- and peri-menopausal women receiving either 1
           liter per day of FIJI water (A) or 1 liter per day of purified drinking water with no
           minerals (B). During screening we will ask prospective participants about their
           menopausal status (where post-menopausal means having no menstrual period for one year),
           block on their menopausal status, and randomize to either Treatment A or Treatment B.
           There will be 7-8 post-menopausal women and 7-8 pre- or peri-menopausal women in each
           group.

        2. To determine silicon absorption by measuring urinary silicon excretion

        3. To determine bone resorption and turn over markers by measuring urinary N-Telopeptide,
           serum bone alkaline phosphatase, osteocalcin, procollagen Type I Intact N-Terminal
           Propeptide, 25 hydroxyvitamin D, parathyroid hormone (PTH) and calcium.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Silicon Absorption at 12 Weeks</measure>
    <time_frame>12 Weeks</time_frame>
    <description>Change from baseline in silicon absorption in response to silicon-rich water (Fiji) supplementation for 12 weeks was determined by measuring urinary solicon concentration (mg/mg) normalized to creatinine.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Bone Diseases, Metabolic</condition>
  <arm_group>
    <arm_group_label>Fiji Water</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are asked to consume one liter of this silicon-rich water daily for three months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aquafina Water</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants are asked to drink one liter of this deionized water daily for three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fiji Water</intervention_name>
    <description>Participants are asked to drink one liter of this silicon-rich water daily for three months.</description>
    <arm_group_label>Fiji Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) &lt; 30

          -  Postmenopausal women with no evidence of osteoporosis by dual energy X-ray
             absorptiometry (DEXA) scan (T ≥ -2 in the total hip and lumbar spine).

          -  Pre- or peri-menopausal women with osteopenia but no evidence of osteoporosis by DEXA
             scan (−1.5 ≤ T ≤ −2 in the total hip and lumbar spine)

          -  No estrogens or corticosteroids

          -  No prior history of bisphosphonate medication

          -  Otherwise in good health with no significant illnesses which could affect bone
             metabolism such as hypercortisolism, untreated hypothyroidism, treatment with statins
             or other drugs affecting bone metabolism other than calcium and vitamin D3.

          -  No change in exercise regimen or calcium intake in the past 3 months.

          -  Subject must sign the Institutional Review Board-approved written informed consent
             prior to the initiation of any study specific procedures or randomization. A subject
             will be excluded for any condition that might compromise the ability to give truly
             informed consent for participation in the study.

        Exclusion Criteria:

          -  Males

          -  Premenopausal women with DEXA T scores ≥ -1.5 or ≤ -2.

          -  Postmenopausal women with DEXA T scores ≤ -2.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Heber, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 8, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <results_first_submitted>October 6, 2016</results_first_submitted>
  <results_first_submitted_qc>May 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 23, 2019</results_first_posted>
  <last_update_submitted>May 15, 2019</last_update_submitted>
  <last_update_submitted_qc>May 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Zhaoping Li</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects will be recruited by posting flyers around the UCLA campus community. Initial eligibility will be determined by a telephone conversation in which the study procedures and inclusion/exclusion criteria are reviewed.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Fiji Water</title>
          <description>Participants are asked to consume 1 liter of this silicon-rich water daily for 12 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Aquafina Water</title>
          <description>Participants are asked to drink 1 liter of this deionized water daily for 12 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fiji Water</title>
          <description>Participants are asked to consume 1 liter of this silicon-rich water (Fiji) daily for 12 weeks.</description>
        </group>
        <group group_id="B2">
          <title>Aquafina Water</title>
          <description>Participants are asked to drink 1 liter of this deionized water daily for 12 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.1" spread="6.5"/>
                    <measurement group_id="B2" value="54.4" spread="3.9"/>
                    <measurement group_id="B3" value="53.75" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Silicon Absorption at 12 Weeks</title>
        <description>Change from baseline in silicon absorption in response to silicon-rich water (Fiji) supplementation for 12 weeks was determined by measuring urinary solicon concentration (mg/mg) normalized to creatinine.</description>
        <time_frame>12 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aquafina Water</title>
            <description>Participants are asked to drink 1 liter of this deionized water daily for 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Fiji Water</title>
            <description>Participants are asked to drink 1 liter of this silicon-rich water daily for 12 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Silicon Absorption at 12 Weeks</title>
          <description>Change from baseline in silicon absorption in response to silicon-rich water (Fiji) supplementation for 12 weeks was determined by measuring urinary solicon concentration (mg/mg) normalized to creatinine.</description>
          <units>mg/mg creatinine</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline silicon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.010" spread="0.004"/>
                    <measurement group_id="O2" value="0.016" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 week silicon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.009" spread="0.006"/>
                    <measurement group_id="O2" value="0.037" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison was made to 12 weeks minus baseline change in Fiji water group</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>p&lt;0.05 was defined as significant</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Comparison was made to the 12 week minus baseline change in Aquafina (control) group</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <p_value_desc>p&lt;0.05 was defined as significant</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fiji Water</title>
          <description>Participants are asked to consume 1 liter of this silicon-rich water (Fiji) daily for three months.</description>
        </group>
        <group group_id="E2">
          <title>Aquafina Water</title>
          <description>Participants are asked to drink 1 liter of this deionized water daily for 12 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular Health</sub_title>
                <description>One subject was withdrawn by the investigator concerning her cardiovascular health (not specified).</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Zhaoping Li</name_or_title>
      <organization>UCLA Center for Human Nutrition</organization>
      <phone>310-206-1987</phone>
      <email>zli@mednet.ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

